Design, synthesis, and evaluation of 2-aryl-7-(3′,4′-dialkoxyphenyl)-pyrazolo[1,5-a]pyrimidines as novel PDE-4 inhibitors
作者:Ikyon Kim、Jong Hwan Song、Chang Min Park、Joon Won Jeong、Hyung Rae Kim、Jin Ryul Ha、Zaesung No、Young-Lan Hyun、Young Sik Cho、Nam Sook Kang、Dong Ju Jeon
DOI:10.1016/j.bmcl.2009.12.070
日期:2010.2
is design, synthesis, and biological evaluation of novel series of 2-aryl-7-(3′,4′-dialkoxyphenyl)-pyrazolo[1,5-a]pyrimidines acting as inhibitors of type 4 phosphodiesterase (PDE4) which is known as a good target for the treatment of asthma and COPD. For this purpose, structure optimization was conducted with the aid of structure-based drug design using the known X-ray crystallography. Also, biological
本文描述了新颖的2-芳基-7-(3',4'-二烷氧基苯基)-吡唑并[1,5- a ]嘧啶系列的新颖系列的设计,合成和生物学评估,该抑制剂可作为4型磷酸二酯酶(PDE4)的抑制剂被认为是治疗哮喘和COPD的好靶标。为此目的,使用已知的X射线晶体学,借助于基于结构的药物设计进行结构优化。此外,通过使用体外测定法评估了这些化合物对目标酶的生物学作用,从而产生了有效且选择性的PDE-4抑制剂(IC 50 <10 nM)。